Delivery Order SPE2DB24D2018-SPE2DB25FWSR1
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,264.89 firm fixed-price delivery order contract is for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product, to support federal healthcare programs. The award has an ultimate completion date of November 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.59 Firm Fixed Price Delivery Order, with a completion date of March 1, 2023, is for the supply of 4560094860 - TRILEPTAL 300 MG/5 ML SUSP 250ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, identified as SPE2DB20D3505|SPE2DB24FT2X1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product, with a ceiling value of $1,785.44 and a completion date of October 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trileptal 300 mg/5 ml suspension, a 250 ml medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,067.32 and an ultimate completion date of May 23, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,067.99 firm fixed-price contract is for the supply of Trileptal 300 mg/5 ml suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The contract is a firm-fixed price delivery order with a ceiling value of $1,099.02 and a period of performance through March 22, 2023. AmerisourceBergen is the prime contractor, and there is no indication of any set-aside requirements for this award. This contract is part of a larger...
This federal contract award, valued at $2,853.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles, with a completion date of May 31, 2023. This contract is not designated as a set-aside and is issued as a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, with ID SPE2DB22D2007|SPE2DB24FH7US, was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,201.84 firm fixed-price delivery order is for the supply of 4563062395 - TRILEPTAL 300 MG/5 ML SUSP 250ML, with a completion date of December 12, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award, valued at $7,004.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Trileptal 300 mg tablets, a medication used to treat seizure disorders. The contract is a Firm Fixed Price Delivery Order with a completion date of May 14, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and the company is a subsidiary of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The award, valued at $5,180.00, is a firm-fixed price contract without any set-aside designation. The period of performance for this delivery order extends through August 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...